CLINICAL_TRIALS
trial_result
· 2017-01-10
Clinical Trial Update: Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis [Phase 1, Phase 2]
Summary
A completed Phase 1/2 trial evaluated the safety and efficacy of Deoxyspergualin (NKT-01) in patients with lupus nephritis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Lupus Nephritis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-01-10